Quo vadis cancer therapyis the title ofProf. Dr. Schirrmacher's new book, a comprehensive guide to cancer. It explains treatment modalities and how they came about—especially with regard to the development of biological therapies in recent decades. It highlights milestones in molecular biology, cancer biology, immunology, virology, and physiology. Another important part is the comparison of immunotherapies with all other forms of cancer therapy.

The book is an appeal to the healthcare system to supplement and modernize standard forms of therapy with novel forms of therapy. Cancer therapies should incorporate more components from immunotherapy, which reduce side effects and improve the long-term effectiveness of treatment. The book is published by Lambert Academic Publishing in English.